Serum albumin in ischemic stroke patients: The higher the better:

Cerebrovascular Diseases

Volumn 28, Issue 1, 2009, Pages 13-17

  Idicula, Titto T ^a   Waje Andreassen, Ulrike ^a   Brogger, Jan ^a   Naess, Halvor ^a   Thomassen, Lars ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Ischemic stroke; Neuroprotection; Serum albumin

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; SERUM ALBUMIN;

AGED; ALBUMIN BLOOD LEVEL; ARTICLE; ATHEROSCLEROSIS; BLOOD CLOT LYSIS; BLOOD VESSEL OCCLUSION; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EMBOLISM; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURVIVAL;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NORWAY; PROGNOSIS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; SERUM ALBUMIN; SEVERITY OF ILLNESS INDEX; STROKE;

EID: 65449165296     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000215938     Document Type: Article

References (19)

1. Ferro JM, Davalos A: Other neuroprotective therapies on trial in acute stroke. Cerebro- vasc Dis 2006;21(suppl 2):127-130.
2. Belayev L, Pinard E, Nallet H, Seylaz J, Liu Y, Riyamongkol P, Zhao W, Busto R, Ginsberg MD: Albumin therapy of transient focal cerebral ischemia: in vivo analysis of dynamic microvascular responses. Stroke 2002; 33: 1077-1084.
3. Belayev L, Busto R, Zhao W, Clemens JA, Ginsberg MD: Effect of delayed albumin he- modilution on infarction volume and brain edema after transient middle cerebral artery occlusion in rats. J Neurosurg 1997;87:595-601.
4. Dziedzic T, Slowik A, Szczudlik A: Serum albumin level as a predictor of ischemic stroke outcome. Stroke 2004;35:e156-e158.
5. Wahlgren N, Ahmed N, Davalos A, Ford GA, Grond M, Hacke W, Hennerici MG, Kaste M, Kuelkens S, Larrue V, Lees KR, Roine RO, Soinne L, Toni D, Vanhooren G: Thromboly- sis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 2007; 369:275-282.
6. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C: Classification and natural history of clinically identifiable subtypes of cerebralinfarction. Lancet 1991; 337: 1521-1526.
7. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE III:Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 inAcute Stroke Treatment. Stroke 1993; 24:35-41.
8. Toni D, Chamorro A, Kaste M, Lees K, Wahl- gren NG, Hacke W: Acute treatment of isch- aemic stroke. European Stroke Initiative. Cerebrovasc Dis 2004;17(suppl 2):30-46.
9. Reinhart WH, Nagy C: Albumin affects erythrocyte aggregation and sedimentation. Eur J Clin Invest 1995; 25: 523-528.
10. Park HP, Nimmagadda A, DeFazio RA, Bu- sto R, Prado R, Ginsberg MD: Albumin therapy augments the effect of thrombolysis on local vascular dynamics in a rat model of ar- teriolar thrombosis: a two-photon laser- scanning microscopy study. Stroke 2008;39: 1556-1562.
11. Palesch YY, Hill MD, Ryckborst KJ, Tamariz D, Ginsberg MD: The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke - II: neurologic outcome and efficacy analysis. Stroke 2006;37:2107-2114.
12. Halliwell B: Albumin - an important extracellular antioxidant? Biochem Pharmacol 1988; 37: 569-571.
13. Parkkinen J, Ojala P, Niiranen J, Jolkkonen J: Molecular mechanisms underlying neuro- protective effects of albumin after ischemic stroke. Stroke 2007; 38: 255.
14. Huh PW, Belayev L, Zhao W, Busto R, Saul I, Ginsberg MD: The effect of high-dose albumin therapy on local cerebral perfusion after transient focal cerebral ischemia in rats. Brain Res 1998; 804:105-113.
15. Shin DH, Moon GJ, Bang OY: Albumin therapy in acute stroke patients. J Neurol 2007;254:870-878.
16. Koch S, Concha M, Wazzan T, Romano JG, Forteza A: High dose human serum albumin for the treatment of acute ischemic stroke: a safety study. Neurocrit Care 2004; 1: 335-341.
17. Yoo SH, Kim JS, Kwon SU, Yun SC, Koh JY, Kang DW: Undernutrition as a predictor of poor clinical outcomes in acute ischemic stroke patients. Arch Neurol 2008; 65: 39-43.
18. Ali M, Atula S, Bath PM, et al: Stroke outcome in clinical trial patients deriving fromb different countries. Stroke 2009;40:35-40.
19. Davalos A, Ricart W, Gonzalez-Huix F, Soler S, Marrugat J, Molins A, et al: Effect of malnutrition after acute stroke on clinical outcome. Stroke 1996; 27: 1028-1032.